Leon Kujmanian, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1146 N. Central Avenue, #522, Glendale, CA 91202 Phone: 818-500-0910 Fax: 818-500-0914 |
Dr. Zarmen Israelian, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr, #102, Glendale, CA 91205 Phone: 818-265-2242 Fax: 818-265-2241 |
Jhanna Alexandra Nariyants, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1812 Verdugo Blvd, Glendale, CA 91208 Phone: 818-790-7100 |
Eliana Y Berger, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1500 S Central Ave Ste 200, Glendale, CA 91204 Phone: 818-956-8582 |
Mr. Oliver Lim Ong, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 801 S Chevy Chase Dr, #102, Glendale, CA 91205 Phone: 818-265-2242 Fax: 818-265-2241 |
Martin N Montoro, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1500 S Central Ave, 326, Glendale, CA 91204 Phone: 818-956-8582 Fax: 818-956-0329 |
News Archive
A mother's exposure to urban air pollutants known as polycyclic aromatic hydrocarbons (PAHs) can adversely affect a child's intelligence quotient or IQ, a study reports. PAHs are chemicals released into the air from the burning of coal, diesel, oil and gas, or other organic substances such as tobacco. In urban areas motor vehicles are a major source of PAHs.
Medical products, packaging and food can be safely and efficiently sterilized with electron beams.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review.
Using this garment-based patient biomonitoring platform allows us to register a number of the patient's physiological parameters in a non-intrusive manner. "The information gathered by an intelligent t-shirt using e-textile technology is sent, without using wires, to an information management system, which then shows the patient's location and vital signs in real time", explain the UC3M researchers.
› Verified 4 days ago